ADVANCEMENTS IN HEART FAILURE TREATMENT: CURRENT STRATEGIES AND FUTURE  DIRECTIONS OF PHARMACOTHERAPY

Pulatova N. I., Yakubov A.V

dc.contributor.author	Pulatova N. I., Yakubov A.V
dc.date.accessioned	2024-01-16T05:35:57Z
dc.date.available	2024-01-16T05:35:57Z
dc.date.issued	2023
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/10267
dc.description.abstract	The importance and necessity of further research into this pathological syndrome are determined by the high incidence of chronic heart failure (CHF) in the population (1-2%), an increase in the average age of newly diagnosed patients, a progressive course, the need for inpatient treatment, and an unfavorable prognosis. This article discusses new, effective directions for the pharmacological and non-drug correction of cardiac dysfunction in the treatment of CHF patients, numerous evolutionary changes in the heart failure problem, strategies for enhancing quality of life, and life expectancy for CHF patients.	en_US
dc.language.iso	en_US	en_US
dc.publisher	Ўзбекистон, Тошкент	en_US
dc.relation.ispartofseries	УДК;616-08-039.73.-616.12-008
dc.subject	chronic heart failure, pharmacotherapy, pathogenetic treatment	en_US
dc.title	ADVANCEMENTS IN HEART FAILURE TREATMENT: CURRENT STRATEGIES AND FUTURE DIRECTIONS OF PHARMACOTHERAPY	en_US
dc.type	Article	en_US